Philippines approves Pfiser-BioNTech vaccine for emergency use

14-Jan-2021 Intellasia | Reuters | 12:10 PM Print This Post

The Philippines’ Food and Drug Administration has authorised the emergency use of Pfiser Inc and BioNTech SE’s COVID-19 vaccine, its head said on Thursday.

The Pfiser-BioNTech vaccine, which has shown a 95 percent success rate, is the first vaccine the Philippines has approved.

FDA head Rolando Enrique Domingo told a media briefing China’s Sinovac Biotech Ltd on Wednesday submitted to regulators its emergency use authorisation application.


Category: Philippines

Print This Post

Comments are closed.